Nevertheless, a genome-wide association study conducted in 2013 with rosuvastatin found no increased risk of myalgia in its users carrying the rs4363657C or rs4149056C alleles in the SLCO1B1 gene [59]. Here, SLCO1B1 is linked to Myalgia.